Holen Sie sich die Stockscreener-App
323.86
0.56%
-2.155
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$326.01
Offen:
$326.27
24-Stunden-Volumen:
1.62M
Relative Volume:
0.61
Marktkapitalisierung:
$174.53B
Einnahmen:
$35.89B
Nettoeinkommen (Verlust:
$7.01B
KGV:
25.04
EPS:
12.9352
Netto-Cashflow:
$11.54B
1W Leistung:
+2.15%
1M Leistung:
-5.76%
6M Leistung:
+11.93%
1J Leistung:
+25.28%
1-Tages-Spanne:
$321.91
$328.24
1-Wochen-Bereich:
$315.19
$332.80
52-Wochen-Spanne:
$253.30
$346.38
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
324.12 | 175.55B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,062.75 | 932.42B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
208.83 | 506.75B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
223.96 | 396.44B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
135.38 | 259.09B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
101.29 | 246.17B | 63.90B | 19.05B | 13.05B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Inductive Bio, Amgen Join ARPA-H’s Push To Replace Animal Tox With AI And Human Tissues - Citeline News & Insights
2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen
HSBC turns more bullish on Amgen (AMGN) into 2026 - MSN
HSBC Turns More Bullish on Amgen (AMGN) into 2026 - Insider Monkey
Amgen (AMGN) Among Pharma Giants in Drug Pricing Talks - GuruFocus
Thurston Springer Miller Herd & Titak Inc. Reduces Stake in Amgen Inc. $AMGN - MarketBeat
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Amgen stock rating maintained by Oppenheimer with price target of $380 - Investing.com UK
Sanders Morris Harris LLC Takes $1.21 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc - MarketBeat
Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease - Insider Monkey
Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts - ts2.tech
3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most - Investing.com
Aaron Wealth Advisors LLC Has $51.17 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
How Amgen’s New CD19-Targeted gMG Approval At Amgen (AMGN) Has Changed Its Investment Story - Yahoo Finance
What Amgen (AMGN)'s Expanded UPLIZNA Approval in Generalized Myasthenia Gravis Means For Shareholders - simplywall.st
Amgen (AMGN) Rises As Market Takes a Dip: Key Facts - Yahoo Finance Singapore
Goldman Sachs, Amgen share gains lead Dow's 125-point climb - MSN
Amgen sees RS rating improve to 71 - MSN
Valeo Financial Advisors LLC Has $6.47 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lowered by Texas Permanent School Fund Corp - MarketBeat
Stance Capital LLC Acquires Shares of 4,463 Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Corient Private Wealth LLC - MarketBeat
30,728 Shares in Amgen Inc. $AMGN Acquired by Caldwell Trust Co - MarketBeat
B. Riley Wealth Advisors Inc. Invests $1.65 Million in Amgen Inc. $AMGN - MarketBeat
Advisory Services Network LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Sees RS Rating Improve To 71 - Investor's Business Daily
Amgen (NASDAQ:AMGN) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech
Amgen’s New Study on Maridebart Cafraglutide: A Potential Game-Changer in Obesity Treatment? - TipRanks
Amgen’s New Phase 3 Trial: A Potential Game-Changer for Obstructive Sleep Apnea Treatment - TipRanks
Provident Investment Management Inc. Invests $1.29 Million in Amgen Inc. $AMGN - MarketBeat
Thrivent Financial for Lutherans Increases Position in Amgen Inc. $AMGN - MarketBeat
MASTERINVEST Kapitalanlage GmbH Invests $2.77 Million in Amgen Inc. $AMGN - MarketBeat
Neuberger Berman Group LLC Grows Position in Amgen Inc. $AMGN - MarketBeat
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - Yahoo Finance
Rexford Capital Inc. Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
China Universal Asset Management Co. Ltd. Has $16.87 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Coppell Advisory Solutions LLC Has $1.36 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN)’s Valuation After FDA Approval of Uplizna for Generalized Myasthenia Gravis - simplywall.st
Treasurer of the State of North Carolina Boosts Stake in Amgen Inc. $AMGN - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Has $23.15 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Bellevue Group AG Sells 56,827 Shares of Amgen Inc. $AMGN - MarketBeat
Banque Transatlantique SA Sells 141,712 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen’s Uplizna Approved For Its Largest And Most Competitive Indication Yet - Citeline News & Insights
FDA Grants Orphan Status to Amgen's (AMGN) Blinatumomab for Leuk - GuruFocus
Amgen (AMGN) Receives Maintained Rating, Price Target Lowered to - GuruFocus
FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease - Yahoo Finance
FDA Approves Amgen's Drug For Rare Muscle Disorder - Benzinga
Amgen (AMGN) Gains FDA Nod for Expanded Use of Uplizna in Myasth - GuruFocus
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):